Philip Campbell
Overview
Explore the profile of Philip Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maroni M, Barton M, Lynch K, Deshwar A, Campbell P, Millard J, et al.
medRxiv
. 2024 Nov;
PMID: 39574879
Individuals with monoallelic pathogenic variants in the histone lysine methyltransferase DOT1L display global developmental delay and varying congenital anomalies. However, the impact of monoallelic loss of remains unclear. Here, we...
2.
Foley P, Kalra P, Cleland J, Petrie M, Kalra P, Squire I, et al.
Eur J Heart Fail
. 2024 Oct;
27(1):166-173.
PMID: 39453738
Aims: Concerns exist that intravenous (IV) iron might increase the risk of infections. The IRONMAN trial provided an opportunity to investigate whether giving IV ferric derisomaltose (FDI) to patients with...
3.
Phalen P, Jones N, Davis B, Sarpal D, Dickerson F, Vatza C, et al.
Schizophr Res
. 2024 Sep;
274:150-157.
PMID: 39298811
Background: People experiencing their first episode of psychosis have high risk of suicide, and programs specializing in early psychosis have not always achieved reduced risk. The present study analyzes patterns...
4.
Mollee P, Reynolds J, Janowski W, Quach H, Campbell P, Gibbs S, et al.
Blood Adv
. 2024 May;
8(14):3721-3730.
PMID: 38739707
In newly diagnosed transplant-ineligible patients with myeloma, daratumumab has improved outcomes when added to the standard-of-care regimens. In a randomized trial, we tested whether similar improvements would be observed when...
5.
Kluge A, Borsche M, Streubel-Gallasch L, Gul T, Schaake S, Balck A, et al.
Ann Neurol
. 2024 Mar;
95(6):1173-1177.
PMID: 38546204
Pathogenic variants in PRKN cause early-onset Parkinson's disease (PD), while the role of alpha-synuclein in PRKN-PD remains uncertain. One study performed a blood-based alpha-synuclein seed amplification assay (SAA) in PRKN-PD,...
6.
Baker R, Gilmore G, Chen V, Young L, Merriman E, Curnow J, et al.
Res Pract Thromb Haemost
. 2023 Aug;
7(5):100196.
PMID: 37601024
Background: Restoring hemostasis in patients on oral anticoagulants presenting with major hemorrhage (MH) or before surgical intervention has changed, with the replacement of vitamin K antagonist (VKA) with direct oral...
7.
Burbury K, Brooks P, Gilham L, Solo I, Piper A, Underhill C, et al.
J Telemed Telecare
. 2022 Dec;
30(8):1270-1284.
PMID: 36484151
Introduction: The Victorian COVID-19 Cancer Network (VCCN) Telehealth Expert Working Group aimed to evaluate the telehealth (TH) experience for cancer patients, carers and clinicians with the rapid uptake of TH...
8.
Ghia P, Pluta A, Wach M, Lysak D, Simkovic M, Kriachok I, et al.
Hemasphere
. 2022 Nov;
6(12):e801.
PMID: 36398134
Acalabrutinib is a Bruton tyrosine kinase inhibitor approved for patients with chronic lymphocytic leukemia (CLL). ASCEND is the pivotal phase 3 study of acalabrutinib versus investigator's choice of idelalisib plus...
9.
Tan J, Wellard C, Moore E, Mollee P, Rajagopal R, Quach H, et al.
Br J Haematol
. 2022 Nov;
200(2):e17-e21.
PMID: 36321478
No abstract available.
10.
Bradshaw A, Campbell P, Schapira A, Morris H, Taanman J
PLoS One
. 2021 Nov;
16(11):e0259903.
PMID: 34762687
Mutations in the PINK1 and PRKN genes are the most common cause of early-onset familial Parkinson disease. These genes code for the PINK1 and Parkin proteins, respectively, which are involved...